Asia Pacific Multiomics Market (2026-2031)
The Asia Pacific Multiomics Market was valued at $716.7 Million in 2026 and projected to reach to $1341.2 Million by 2031, representing a compound annual growth rate of 13.4%. The Asia Pacific multiomics market is positioned for sustained growth through 2031, driven by increasing healthcare expenditure, government support for precision medicine, and growing adoption of integrated omics technologies in clinical diagnostics.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific Multiomics Market Trends and Insights
- Asia Pacific's multiomics sector is driven by increasing adoption of integrated genomic, proteomic, and metabolomic technologies across research institutions and clinical laboratories.
- The region's growth trajectory reflects rising healthcare investments, expanding precision medicine initiatives, and growing demand for advanced diagnostic solutions across countries including China, Japan, South Korea, and India. Asia Pacific multiomics market growth is accelerated by strengthening biotechnology ecosystems and government support for genomic research programs.
- Between 2026 and 2031, Asia Pacific is expected to capture significant market share through enhanced laboratory infrastructure and collaborative research partnerships.
- The region's multiomics adoption is further supported by declining sequencing costs and increasing awareness of personalized medicine applications among healthcare providers and pharmaceutical companies..
Key Market Statistics
- CAGR (2026-2031) 13.4% CAGR
- Market Size, 2026 ~USD 716.7 Million
- Forecast, 2031 ~USD 1341.2 Million
- Geography Asia Pacific
Asia Pacific Multiomics Market Overview
Rapid Market Expansion :
Asia Pacific multiomics market is projected to grow from $716.7 million in 2026 to $1,341.2 million by 2031, representing a robust 13.4% CAGR, outpacing the global growth rate of 12.3%.
China's Market Leadership :
China dominates the Asia Pacific multiomics sector with a market size of $384.9 million, driven by substantial investments in genomic research infrastructure and precision medicine initiatives across major research institutions.
Technology Integration Surge :
Increasing adoption of integrated genomic, proteomic, and metabolomic technologies across Asia Pacific research institutions and clinical laboratories is accelerating multiomics platform deployment and clinical applications.
Emerging Market Opportunities :
India ($147 million), Japan ($217.6 million), and South Korea ($155.5 million) represent significant growth opportunities, supported by rising healthcare investments and expanding biotechnology sectors in the region.
Asia Pacific Multiomics Market Dynamics
- Key markets including China, Japan, and India are investing heavily in genomic research infrastructure and personalized medicine initiatives, creating favorable conditions for multiomics platform expansion. Regional growth will be further accelerated by rising prevalence of chronic diseases, expanding pharmaceutical R&D activities, and strengthening collaborations between academic institutions and industry players.
- The region's competitive advantage in manufacturing and cost-effective research capabilities positions Asia Pacific as a critical hub for multiomics innovation and commercialization through the forecast period..
Market Ecosystem
MULTIOMICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides Illumina Connected Multiomics, a cloud-based platform that integrates and analyzes genomics, transcriptomics, proteomics, epigenomics, and other multiomic datasets. For example, oncology researchers at the University of Colorado Anschutz Medical Campus used the platform to analyze proteomic data and generate insights into melanoma biology. | Enables integrated analysis of multiple biological data layers, helping researchers identify biomarkers, understand disease mechanisms, and accelerate precision medicine and drug discovery. (Illumina) |
 |
Provides Chromium Single Cell Multiome ATAC + Gene Expression technology, enabling simultaneous profiling of chromatin accessibility and gene expression in individual cells. Its platforms are widely used in cancer, immunology, and developmental biology research to characterize cellular states and regulatory mechanisms. | Provides a comprehensive view of gene regulation at single-cell resolution, helping researchers link regulatory elements with gene expression and identify disease-associated cell populations. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Asia Pacific multiomics market will grow from $716.7M (2026) to $1,341.2M (2031) at a 13.4% CAGR.
- Asia Pacific's multiomics adoption is driven by precision medicine initiatives and government genomic research funding.
- Asia Pacific multiomics expansion is supported by declining sequencing costs and improved laboratory infrastructure.
- Asia Pacific multiomics market benefits from increasing pharmaceutical and biotech investment in personalized medicine applications.
Multiomics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12.3% from 2026 to 2031 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 3.19 (2026) |
| Revenue Forecast (Billions) | ~USD 5.7 (2031) |
| Segments Covered | Offering, Type, Technology, Method, Workflow, Application, End User |
Asia Pacific Multiomics Market Report Segmentation
7 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Assay Kits & Reagents
- Consumables
- Instruments & Software
- Long-Read Sequencing
- Ms-Based Proteomics
- Nanopore Sequencing
- Ngs-Based Proteomics
- Other Consumables
- Other Proteomics Methods
- Other Sequencing Technologies
- Pcr-Based Proteomics
- Smrt Sequencing
By Technology
- Long-Read Sequencing
- Nanopore Sequencing
- Other Sequencing Technologies
- Other Technologies
- Proteomics
- Sequencing
- Smrt Sequencing
By Method
- Chromatin Accessibility Sequencing
- Chromatin Interaction Analysis
- Dna Methylation Sequencing
- Epigenomics
- Histone Modification Profiling
- Long-Range Sequencing
- Long-Read & Long-Range Sequencing
- Long-Read Sequencing
- Ms-Based Proteomics
- Ngs-Based Proteomics
- Other Epigenomics Methods
- Other Long-Read & Long-Range Sequencing Methods
- Other Methods
- Other Proteomics Methods
- Other Single-Cell Omics
- Other Spatial Omics
- Pcr-Based Proteomics
- Proteomics
- Sequencing-Based Epigenomics
- Single-Cell Epigenomics
- Single-Cell Genomics
- Single-Cell Omics
- Single-Cell Proteomics
- Single-Cell Transcriptomics
- Spatial Epigenomics
- Spatial Genomics
- Spatial Omics
- Spatial Proteomics
- Spatial Transcriptomics
By Workflow
- Data Visualization & Analysis
- Sample Preparation
- Sequencing & Analysis/ Sample Characterization
- Sequencing & Analysis/Sample Characterization
By Application
- Biomarker Discovery
- Cell Biology
- Clinical Diagnostics
- Drug Discovery & Development
- Immunology
- Neurology
- Oncology
- Other Applications
- Precision Medicine
- Translational Research
By End User
- Academic & Research Institutes
- Cros & Cdmos
- Hospitals & Diagnostic/Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical & Biotech Companies : Need Asia Pacific market insights to guide R&D investments, clinical trial planning, and commercialization strategies for multiomics-based diagnostics and therapeutics in high-growth markets.
- Diagnostic Laboratory Operators : Require regional market data to assess multiomics technology adoption rates, competitive positioning, and expansion opportunities across Asia Pacific clinical and research laboratory segments.
- Healthcare Technology Investors : Seek Asia Pacific-specific market forecasts and growth drivers to identify investment opportunities in multiomics platforms, genomic services, and precision medicine companies across the region.
- Research Institution Leaders : Need regional market intelligence to benchmark multiomics capabilities, identify collaboration opportunities, and secure funding for genomic and proteomic research initiatives in Asia Pacific.
- Healthcare Policy & Government Officials : Require market data to inform precision medicine policies, healthcare infrastructure investments, and regulatory frameworks supporting multiomics adoption across Asia Pacific healthcare systems.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 384.9 Million |
| Japan | USD 217.6 Million |
| South Korea | USD 155.5 Million |
| India | USD 147 Million |
| Australia | USD 83.5 Million |
| Rest Of Asia Pacific | USD 110.5 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Access detailed market valuations for Asia Pacific and individual country-level data (China, Japan, India, South Korea, Australia) with 5-year projections through 2031 to inform strategic planning.
- Competitive Landscape Intelligence : Understand market dynamics specific to Asia Pacific, including key players, technology adoption rates, and regional competitive positioning to identify partnership and investment opportunities.
- Growth Driver Analysis : Gain insights into Asia Pacific-specific growth catalysts including healthcare investments, regulatory environment, precision medicine adoption, and emerging market opportunities across the region.
- Country-Level Market Breakdown : Evaluate individual country markets within Asia Pacific to prioritize market entry strategies, identify high-growth segments, and allocate resources to the most promising geographies.
- Strategic Decision Support : Leverage Asia Pacific-focused market intelligence to support product development, go-to-market strategies, partnership decisions, and investment allocation in the fastest-growing multiomics region globally.
Frequently asked questions
What is the current size of the Asia Pacific multiomics market?
The Asia Pacific multiomics market is valued at $716.7 million in 2026 and is projected to grow to $1,341.2 million by 2031.
What is the CAGR for Asia Pacific multiomics market growth?
Asia Pacific multiomics market is expected to grow at a compound annual growth rate (CAGR) of 13.4% from 2026 to 2031.
Which countries drive Asia Pacific multiomics market expansion?
Key markets in Asia Pacific multiomics include China, Japan, South Korea, and India, which are investing heavily in precision medicine and genomic research infrastructure.
What factors are accelerating Asia Pacific multiomics market growth?
Asia Pacific multiomics growth is driven by declining sequencing costs, government research funding, expanding biotech ecosystems, and increasing adoption of personalized medicine in clinical settings.
How does Asia Pacific multiomics market compare to global trends?
Asia Pacific multiomics market growth at 13.4% CAGR outpaces the global multiomics market CAGR of 12.3%, reflecting the region's accelerating investment in precision medicine and genomic technologies.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current size of the multiomics market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. The secondary sources referred for this research study include publications from government sources, such as the National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), European Bioinformatics Institute (EMBL-EBI), US Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), and Organisation for Economic Co-operation and Development (OECD). Omics-specific repositories and research initiatives, including Human Protein Atlas, the Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Clinical Proteomic Tumor Analysis Consortium (CPTAC), among several others. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global Multiomics market, and the findings were validated through primary research.
Primary Research
In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the multiomics market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Multiomics Market : Top-Down and Bottom-Up Approach
Data Triangulation
After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.
Market Definition
The multiomics market comprises commercial revenues generated from products and services used to perform integrated multiomics analyses by combining two or more molecular profiling modalities, such as genomics, epigenomics, transcriptomics, proteomics, and spatial or single-cell omics. The market includes instruments, software, assay kits, reagents, consumables, and analytical services supporting advanced multiomics workflows from sample preparation and molecular characterization to data integration, visualization, and interpretation. These technologies are used across research and clinical applications, including oncology, precision medicine, biomarker discovery, translational research, drug discovery, and clinical diagnostics, by pharmaceutical and biotechnology companies, academic and research institutions, hospitals, diagnostic laboratories, CROs, and CDMOs. The market excludes conventional single-omics technologies, routine short-read sequencing workflows, microarray-based molecular profiling, and general laboratory products not specifically designed for integrated multiomics applications.
Key Stakeholders
- Multiomics product & service providers
- Multiomics bioinformatics/data analysis companies
- Venture capitalists and other government funding organizations
- Research and consulting firms
- Hospitals and diagnostic clinics
- Pharmaceutical and biotechnology companies
- Academic and government research institutes
- Life science companies
Report Objectives
- To define, describe, and forecast the multiomics market by offering, method, technology, workflow, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall multiomics market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC Countries (Saudi Arabia (KSA), United Arab Emirates (UAE), and the Rest of GCC Countries) and the Rest of Middle East], and Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe multiomics market, by country
- Further breakdown of the Rest of Asia Pacific multiomics market, by country
Company Analysis
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Cross-segment analysis
Get the Full Multiomics Market Report
Full forecast, segment splits, and company analysis for all Multiomics Market.
- Canada Multiomics Market
- US Multiomics Market
- Germany Multiomics Market
- UK Multiomics Market
- France Multiomics Market
- Italy Multiomics Market
- Spain Multiomics Market
- China Multiomics Market
- Japan Multiomics Market
- South Korea Multiomics Market
- India Multiomics Market
- Australia Multiomics Market
- Brazil Multiomics Market
- Saudi Arabia Multiomics Market
- UAE Multiomics Market
- Rest Of Europe Multiomics Market
- Rest Of Asia Pacific Multiomics Market
- Rest Of Latin America Multiomics Market
- Rest Of GCC Countries Multiomics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
